Sunila Pradeep, PhD

Publications

• B Cells as an Immune-Regulatory Signature in Ovarian Cancer.

  (Gupta P, Chen C, Chaluvally-Raghavan P, Pradeep S.) Cancers (Basel). 2019 Jun 26;11(7).

• GnRH-R-Targeted Lytic Peptide Sensitizes Wild-type Ovarian Cancer to PARP Inhibition.

  (Ma S, Pradeep S, Villar-Prados A, Wen Y, Bayraktar E, Mangala LS, Kim MS, Wu SY, Hu W, Rodriguez-Aguayo C, Leuschner C, Liang X, Ram PT, Schlacher K, Coleman RL, Sood AK.) Mol Cancer Ther. 2019 May;18(5):969-979.

• /PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer.

  (Hisamatsu T, McGuire M, Wu SY, Rupaimoole R, Pradeep S, Bayraktar E, Noh K, Hu W, Hansen JM, Lyons Y, Gharpure KM, Nagaraja AS, Mangala LS, Mitamura T, Rodriguez-Aguayo C, Eun YG, Rose J, Bartholomeusz G, Ivan C, Lee JS, Matsuo K, Frumovitz M, Wong KK, Lopez-Berestein G, Sood AK.) Mol Cancer Ther. 2019 01;18(1):162-172.

• FABP4 as a key determinant of metastatic potential of ovarian cancer.

  (Gharpure KM, Pradeep S, Sans M, Rupaimoole R, Ivan C, Wu SY, Bayraktar E, Nagaraja AS, Mangala LS, Zhang X, Haemmerle M, Hu W, Rodriguez-Aguayo C, McGuire M, Mak CSL, Chen X, Tran MA, Villar-Prados A, Pena GA, Kondetimmanahalli R, Nini R, Koppula P, Ram P, Liu J, Lopez-Berestein G, Baggerly K, S Eberlin L, Sood AK.) Nat Commun. 2018 07 26;9(1):2923.

• Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction.

  (Allen JK, Armaiz-Pena GN, Nagaraja AS, Sadaoui NC, Ortiz T, Dood R, Ozcan M, Herder DM, Haemmerle M, Gharpure KM, Rupaimoole R, Previs RA, Wu SY, Pradeep S, Xu X, Han HD, Zand B, Dalton HJ, Taylor M, Hu W, Bottsford-Miller J, Moreno-Smith M, Kang Y, Mangala LS, Rodriguez-Aguayo C, Sehgal V, Spaeth EL, Ram PT, Wong STC, Marini FC, Lopez-Berestein G, Cole SW, Lutgendorf SK, De Biasi M, Sood AK.) Cancer Res. 2018 06 15;78(12):3233-3242.

• Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens.

  (Nagaraja AS, Dood RL, Armaiz-Pena G, Kang Y, Wu SY, Allen JK, Jennings NB, Mangala LS, Pradeep S, Lyons Y, Haemmerle M, Gharpure KM, Sadaoui NC, Rodriguez-Aguayo C, Ivan C, Wang Y, Baggerly K, Ram P, Lopez-Berestein G, Liu J, Mok SC, Cohen L, Lutgendorf SK, Cole SW, Sood AK.) JCI Insight. 2018 06 07;3(11).

• Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.

  (Mangala LS, Wang H, Jiang D, Wu SY, Somasunderam A, Volk DE, Lokesh GLR, Li X, Pradeep S, Yang X, Haemmerle M, Rodriguez-Aguayo C, Nagaraja AS, Rupaimoole R, Bayraktar E, Bayraktar R, Li L, Tanaka T, Hu W, Ivan C, Gharpure KM, McGuire MH, Thiviyanathan V, Zhang X, Maiti SN, Bulayeva N, Choi HJ, Dorniak PL, Cooper LJ, Rosenblatt KP, Lopez-Berestein G, Gorenstein DG, Sood AK.) JCI Insight. 2018 06 07;3(11).

• ADH1B promotes mesothelial clearance and ovarian cancer infiltration.

  (Gharpure KM, Lara OD, Wen Y, Pradeep S, LaFargue C, Ivan C, Rupaimoole R, Hu W, Mangala LS, Wu SY, Nagaraja AS, Baggerly K, Sood AK.) Oncotarget. 2018 May 18;9(38):25115-25126.

• Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.

  (Zheng Y, Sethi R, Mangala LS, Taylor C, Goldsmith J, Wang M, Masuda K, Karaminejadranjbar M, Mannion D, Miranda F, Herrero-Gonzalez S, Hellner K, Chen F, Alsaadi A, Albukhari A, Fotso DC, Yau C, Jiang D, Pradeep S, Rodriguez-Aguayo C, Lopez-Berestein G, Knapp S, Gray NS, Campo L, Myers KA, Dhar S, Ferguson D, Bast RC Jr, Sood AK, von Delft F, Ahmed AA.) Nat Commun. 2018 02 02;9(1):476.

• Pigment Epithelium-Derived Factor and its Phosphomimetic Mutant Induce JNK-Dependent Apoptosis and P38-Mediated Migration Arrest.

  (Konson A, Pradeep S, D'Acunto CW, Seger R.) Cell Physiol Biochem. 2018;49(2):512-529.

• The role of tumor microenvironment in resistance to anti-angiogenic therapy.

  (Ma S, Pradeep S, Hu W, Zhang D, Coleman R, Sood A.) F1000Res. 2018;7:326.

• ERBB signaling in CTCs of ovarian cancer and glioblastoma.

  (Geethadevi A, Parashar D, Bishop E, Pradeep S, Chaluvally-Raghavan P.) Genes Cancer. 2017 Nov;8(11-12):746-751.